Clinical Trial Update: A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of GDC-6599 in patients with chronic cough related to asthma and COPD co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Cough

Drugs mentioned

• GDC-6599

Snippet

Sponsor: Genentech, Inc. | Conditions: Chronic Refractory Cough (CRC) With Non-atopic Asthma, CRC With Atopic Asthma | Phase 2 | Status: COMPLETED | Results posted: 2025-12-16